(Press-News.org) Triple negative breast cancer (TNBC) is one of the most aggressive and hardest forms of breast cancer to treat, but a new study led by Weill Cornell Medicine suggests a surprising way to stop it from spreading. Researchers have discovered that an enzyme called EZH2 drives TNBC cells to divide abnormally, which enables them to relocate to distant organs. The preclinical study also found drugs that block EZH2 could restore order to dividing cells and thwart the spread of TNBC cells.
“Metastasis is the main reason patients with triple negative breast cancer face poor survival odds,” said senior author Dr. Vivek Mittal, Ford-Isom Research Professor of Cardiothoracic Surgery and member of the Sandra and Edward Meyer Cancer Center at Weill Cornell Medicine. “Our study suggests a new therapeutic approach to block metastasis before it starts and help patients overcome this deadly cancer.”
The findings, published Oct. 2 in Cancer Discovery, challenge the popular notion that cancer treatments should boost cell division errors already occurring in tumor cells beyond the breaking point to induce cell death. When normal cells divide, the chromosomes—DNA “packages” carrying genes—are duplicated and split evenly into two daughter cells. This process goes haywire in many cancer cells, leading to chromosomal instability: too many, too few, or jumbled chromosomes in multiple daughter cells.
“I find the attempt to drive cancer cells over the edge with more chromosomal instability a little concerning because if you don’t reach the right level, it may paradoxically lead to aggressive disease,” Dr. Mittal said. “Instead, our findings suggest that restoring order to cell division by targeting EZH2 can stop them from spreading.”
First author Dr. Shelley Yang Bai began this work as a graduate student and is now a postdoctoral associate with Dr. Mittal in cardiothoracic surgery at Weill Cornell Medicine. Dr. Samuel Bakhoum, who was at Memorial Sloan Kettering Cancer Center at the time, co-led this study.
Linking Epigenetics and Metastasis
About 5% of cells in a TNBC primary tumor are highly likely to metastasize, and these cells have unique features such as different metabolism, increased chromosomal instability and altered epigenetics—modifications to DNA or its associated proteins that do not directly change the genetic code.
Dr. Mittal’s team found a suspicious culprit that could be triggering metastasis in these particular cancer cells: EZH2. This protein normally modifies how DNA is packaged in cells. But cancers often hijack EZH2 by increasing its production. In TNBC, this overproduction leads to the silencing of key genes needed for chromosomes to segregate properly during cell division and to rampant errors.
When analyzing data from breast cancer patients, Dr. Bai found that patients with higher levels of EZH2 also had tumor cells with more chromosomal alterations. This provided clues for further lab experiments. While inhibiting EZH2 with tazemetostat, an FDA-approved drug to treat certain cancers, reduced chromosomal instability in cell lines, boosting EZH2 levels genetically increased errors in cell division.
Furthermore, mouse models with elevated EZH2 and chromosomal instability in primary tumors showed increased lung metastases compared to tumors lacking EZH2, confirming a direct link between EZH2 levels, chromosomal instability and metastasis. But how was EZH2 driving instability?
Chromosomal Chaos
The team discovered that EZH2 silences the tankyrase 1 gene, which normally ensures the chromosome-separating machinery works properly during cell division. This triggers a chain reaction—the decrease in tankyrase 1 causes another protein called CPAP to build up excessively. This prompts the cell’s centrosomes—structures that pull chromosomes apart—to multiply uncontrollably, leading to faulty divisions into three or more daughter cells.
The team showed that inhibiting EZH2 restored balance, significantly reducing metastasis in preclinical models. “For the first time, we have linked EZH2, which is an epigenetic regulator, with chromosomal instability in a mechanistic fashion,” Dr. Bai said.
EZH2 inhibitors may be the first drugs that can suppress chromosomal instability directly. "This study provides a promising new approach to treating triple-negative breast cancer by targeting the root cause of metastases,” said Dr. Magdalena Plasilova, associate professor of clinical surgery (pending appointment at rank), a surgical oncologist at NewYork-Presbyterian/Weill Cornell Medical Center and an author on the study. “I see firsthand the devastating impact of metastases on patients, and this offers hope for improved outcomes and survival rates.”
While Tazemetostat could be repurposed as a treatment for TNBC, other drugs might have similar or better effects. “Our discovery opens the door for clinical trials to test EZH2 inhibitors in high-risk breast cancer and potentially other cancers that are also marked by chromosomal instability, such as lung adenocarcinoma,” said Dr. Mittal, who is also a member of the Englander Institute of Precision Medicine at Weill Cornell. Currently, he is planning collaborations to conduct safety tests in a clinical trial.
END
Study finds restoring order to dividing cancer cells may prevent metastasis
2025-10-03
ELSE PRESS RELEASES FROM THIS DATE:
High-accuracy tumor detection with label-free microscopy and neural networks
2025-10-03
Pancreatic neuroendocrine neoplasms (PNENs) are a rare form of cancer that affects hormone-producing cells in the pancreas. Although uncommon, their incidence has been rising steadily over the past few decades. Treatment options include chemotherapy and targeted therapies, but surgery remains the only chance for a cure. However, surgical decisions often depend on pathology results that can take hours or even days, delaying treatment and increasing the risk of incomplete tumor removal.
Researchers at the University of Arizona have developed a new imaging method that could help surgeons identify cancerous tissue more quickly and accurately. The technique, called multiphoton microscopy ...
Wayne State research reveals fetuses exposed to Zika virus have long-term immune challenges
2025-10-03
DETROIT — A Wayne State University study published in the Oct. 3, 2025, issue of Nature Communications revealed that Zika virus exposure during pregnancy causes long-term, sex-specific changes to a baby’s immune system, particularly affecting the frontline immune cells that fight infection.
The study, “Prenatal exposure to Zika virus shapes offspring neutrophil function in a sex-specific manner,” was led by Dr. Jiahui Ding, assistant professor of obstetrics and gynecology in Wayne State’s School of Medicine.
“We discovered that when a pregnant mother is infected with Zika virus, the resulting inflammatory ...
Researchers deconstruct chikungunya outbreaks to improve prediction and vaccine development
2025-10-03
The symptoms come on quickly — acute fever, followed by debilitating joint pain that can last for months. Though rarely fatal, the chikungunya virus, a mosquito-borne illness, can be particularly severe for high-risk individuals, including newborns and older adults.
While the virus is common in tropical and subtropical regions, including Asia, Africa and South America, public health officials have been tracking reported infections in Europe and, in September, a confirmed case in Long Island, New York.
Outbreaks ...
Study finds one-year change on CT scans linked to future outcomes in fibrotic lung disease
2025-10-03
DENVER (Oct 1, 2025) Researchers at National Jewish Health have shown that subtle increases in lung scarring, detected by an artificial intelligence-based tool on CT scans taken one year apart, are associated with disease progression and survival in patients with fibrotic interstitial lung disease. The findings, recently published in the American Journal of Respiratory and Critical Care Medicine, suggest that computer-based image analysis may provide an earlier, more objective way to identify patients at highest risk for worsening disease.
“We ...
Discovery of a novel intracellular trafficking pathway in plant cells
2025-10-03
Just like in yeast and animal cells, vacuoles in plants are responsible for breaking down unwanted cellular components. At the same time, vacuoles in seeds also serve the opposite role -storing large amounts of proteins that provide energy during germination. These storage proteins, accumulated in the vacuoles of seeds such as beans and wheat, are not only vital for plant growth but also represent an important agricultural resource closely tied to our daily diet.
Until now, it was entirely unknown whether proteins could be transported from the vacuole to other organelles. In a study now published ...
New tool helps forecast volcano slope collapses and tsunamis
2025-10-03
UNIVERSITY PARK, Pa. — For people living near volcanoes, danger goes well beyond lava flows and clouds of ash. Some explosive eruptions can lead to dramatic collapses of the sides of a volcano, like those at Mount St. Helens, Washington, and Anak Krakatau, Indonesia. The latter triggered tsunamis blamed for most deaths from its historic eruptions in 1883.
But the science and exact triggers behind such catastrophes remain largely unknown. To help scientists forecast collapse of volcano sides, also known as flanks or ...
Molecular coating cleans up noisy quantum light
2025-10-03
Quantum technologies demand perfection: one photon at a time, every time, all with the same energy. Even tiny deviations in the number or energy of photons can derail devices, threatening the performance of quantum computers that someday could make up a quantum internet.
While this level of precision is difficult to achieve, Northwestern University engineers have developed a novel strategy that makes quantum light sources, which dispense single photons, more consistent, precise and reliable.
In a new study, the team coated an atomically thin semiconductor (tungsten diselenide) with a sheetlike organic molecule called PTCDA. The coating transformed ...
From Parkinson's to rare diseases, discovered a key switch for cellular health
2025-10-03
A key switch for cellular energy balance has been discovered in cells: it could potentially become the target of new therapies for diseases ranging from Parkinson's to rare disorders caused by defects in the cell's powerhouses, the mitochondria. The switch is called phosphatase B55 (PP2A-B55alpha) and regulates the balance of mitochondria. Experts from Università Cattolica, Rome campus, and Roma Tre Universty have observed that, by reducing its activity, it’s possible to attenuate the motor symptoms of Parkinson's in a preclinical model of the disease.
This is ...
Tiny sugars in the brain disrupt emotional circuits, fueling depression
2025-10-03
Depression is a serious disorder that disrupts daily life through lethargy, sleep disturbance, and social withdrawal, and also increases the risk of suicide. The number of depression patients has steadily increased over the years, affecting more than 280 million people worldwide as of 2025. Now, researchers have uncovered a new pathological mechanism that could provide clues for the diagnosis and treatment of depression.
A research team led by C. Justin LEE and LEE Boyoung at the Institute for Basic Science (IBS) has identified a new molecular pathway in the brain that directly links abnormal sugar modifications on proteins to depressive behaviors. Specifically, ...
Mini-organs reveal how the cervix defends itself
2025-10-03
Cervical epithelial cells are far from passive bystanders in the body’s immune system. New research shows they actually play an active and highly coordinated role in detecting and fighting infections. That’s the conclusion of an international research team led by Associate Professor Cindrilla Chumduri from Aarhus University, and now published in the journal Science Advances.
Using patient-derived 3D mini-organs, so-called organoids, and single-cell mapping technologies, the team has, for the first time, shown how distinct epithelial cell types in the cervix ...